You need JavaScript to view this

Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine

Abstract

Fumonisin B{sub 1} (FB{sub 1}) is a mycotoxin produced by Fusarium verticillioides, commonly present in corn and other cereals. Exposure to FB{sub 1} causes organ-specific diseases in various species, e.g., equine leukoencephalomalacia and porcine pulmonary edema; in mice the response is hepatotoxicity. We earlier reported that ceramide synthase inhibition by FB{sub 1}, the initial biochemical effect of this mycotoxin, results in modulation of cytokine network in response to accumulated free sphingoid bases. In the current study we used NZB/NZW-F1 (NZBW) mice that have modified cytokine expression and develop lupus beginning at 5 months of age. The NZBW and C57BL/6J (CBL) mice (appropriate control) were given five daily subcutaneous injections of either saline or 2.25 mg FB{sub 1}/kg/day and euthanized 24 h after the last treatment. Peripheral leukocyte counts were higher after exposure to FB{sub 1} in CBL but not in NZBW. FB{sub 1} treatment caused increases of plasma alanine aminotransferase and aspartate aminotransferase activity in CBL mice indicating hepatotoxicity; no elevation of circulating liver enzymes was recorded in NZBW mice. Hepatotoxic responses were confirmed by microscopic evaluation of apoptotic cells. The FB{sub 1}-induced proliferation of cells observed in CBL strain was abolished in NZBW animals. The sphinganine accumulation in liver  More>>
Authors:
Sharma, Raghubir P; [1]  Quanren, He; [1]  Riley, Ronald T [2] 
  1. Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602-7389 (United States)
  2. Toxicology and Mycotoxin Research Unit, USDA-ARS, Athens, GA 30604 (United States)
Publication Date:
Dec 01, 2005
Product Type:
Journal Article
Resource Relation:
Journal Name: Toxicology; Journal Volume: 216; Journal Issue: 1; Other Information: DOI: 10.1016/j.tox.2005.07.024; PII: S0300-483X(05)00348-3; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)
Subject:
60 APPLIED LIFE SCIENCES; ALANINES; APOPTOSIS; BIOLOGICAL ACCUMULATION; BIOLOGICAL STRESS; CEREALS; EDEMA; ENZYMES; FUSARIUM; INJURIES; INTERFERON; LEUKOCYTES; LIGANDS; LIVER; LUPUS; METABOLISM; MICE; RECEPTORS; SUBCUTANEOUS INJECTION
OSTI ID:
20720467
Country of Origin:
Ireland
Language:
English
Other Identifying Numbers:
Journal ID: ISSN 0300-483X; TXCYAC; TRN: IE05R0518032967
Submitting Site:
INIS
Size:
page(s) 59-71
Announcement Date:
May 15, 2006

Citation Formats

Sharma, Raghubir P, Quanren, He, and Riley, Ronald T. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine. Ireland: N. p., 2005. Web. doi:10.1016/j.tox.2005.07.024.
Sharma, Raghubir P, Quanren, He, & Riley, Ronald T. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine. Ireland. https://doi.org/10.1016/j.tox.2005.07.024
Sharma, Raghubir P, Quanren, He, and Riley, Ronald T. 2005. "Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine." Ireland. https://doi.org/10.1016/j.tox.2005.07.024.
@misc{etde_20720467,
title = {Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine}
author = {Sharma, Raghubir P, Quanren, He, and Riley, Ronald T}
abstractNote = {Fumonisin B{sub 1} (FB{sub 1}) is a mycotoxin produced by Fusarium verticillioides, commonly present in corn and other cereals. Exposure to FB{sub 1} causes organ-specific diseases in various species, e.g., equine leukoencephalomalacia and porcine pulmonary edema; in mice the response is hepatotoxicity. We earlier reported that ceramide synthase inhibition by FB{sub 1}, the initial biochemical effect of this mycotoxin, results in modulation of cytokine network in response to accumulated free sphingoid bases. In the current study we used NZB/NZW-F1 (NZBW) mice that have modified cytokine expression and develop lupus beginning at 5 months of age. The NZBW and C57BL/6J (CBL) mice (appropriate control) were given five daily subcutaneous injections of either saline or 2.25 mg FB{sub 1}/kg/day and euthanized 24 h after the last treatment. Peripheral leukocyte counts were higher after exposure to FB{sub 1} in CBL but not in NZBW. FB{sub 1} treatment caused increases of plasma alanine aminotransferase and aspartate aminotransferase activity in CBL mice indicating hepatotoxicity; no elevation of circulating liver enzymes was recorded in NZBW mice. Hepatotoxic responses were confirmed by microscopic evaluation of apoptotic cells. The FB{sub 1}-induced proliferation of cells observed in CBL strain was abolished in NZBW animals. The sphinganine accumulation in liver after FB{sub 1} was equal in both strains of mice. The NZBW strain lacked the FB{sub 1}-induced increases in the expression of liver tumor necrosis factor {alpha}, interferon {gamma}, receptor interacting protein (RIP), and tumor necrosis factor {alpha}-related apoptosis-inducing ligand (TRAIL), observed in CBL. Results confirmed our hypothesis that initial altered sphingolipid metabolism caused by FB{sub 1} leads to perturbation of liver cytokine network and ultimate cellular injury; the mice deficient in cytokine signaling are refractory to FB{sub 1} hepatotoxicity.}
doi = {10.1016/j.tox.2005.07.024}
journal = []
issue = {1}
volume = {216}
place = {Ireland}
year = {2005}
month = {Dec}
}